- $44.01m
- $73.60m
- $186.45m
- 79
- 64
- 45
- 66
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 84.4 | 82.4 | 146 | 317 | 186 |
Cost of Revenue | |||||
Gross Profit | 25.1 | 23.5 | 32.4 | 66.2 | 55.7 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 82.8 | 84.2 | 140 | 307 | 184 |
Operating Profit | 1.58 | -1.72 | 6.85 | 9.5 | 2.6 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 0.946 | -2.23 | 6.16 | 0.052 | 0.525 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0.616 | -1.73 | 5.2 | -2.14 | 0.723 |
Net Income Before Extraordinary Items | |||||
Net Income | 0.616 | -1.73 | 5.2 | -2.14 | 0.723 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.297 | -2.4 | 4.44 | -3.13 | 0.439 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.349 | -2.75 | 2.01 | -3.03 | 0.364 |